Skip to main content

Table 4 The process indicatorsa, b

From: A cluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study

Variables

Clinical pathway, n = 238

No intervention, n = 238

Between-group difference, OR (95% CI)

P-valuec

Information, advice, and support from the multidisciplinary team given to the patients (and with their consent, to the caregivers)

204/204 (100) (98.2 to 0.0)

115/133 (86.5) (81.2 to 92.3)

1.16 (1.08 to 1.24)

< 0.001

Use of clinical protocols (see protocol)

221/229 (96.5) (93.2 to 98.5)

83/139 (59.7) (51.1 to 67.9)

18.64 (8.14 to 44.31)

< 0.001

Use of CT/MRI brain scan within 48 hours of admission

223/229 (97.4) (94.4 to 99.0)

209/219 (95.4) (91.8 to 97.8)

1.78 (0.58 to 5.61)

0.31

Aspirin treatment within 48 hours of admission

157/188 (83.5) (77.4 to 88.5)

146/196 (74.5) (67.8 to 80.4)

1.73 (1.02 to 2.75)

0.03

Swallow screen test on day of admission

211/213 (99.1) (96.6 to 99.9)

83/95 (87.4) (79.0 to 93.3)

15.25 (3.14 to 100.96)

< 0.001

Blood pressure assessment

173/197 (87.8) (82.3 to 92.0)

78/191 (40.8) (33.8 to 48.2)

10.44 (6.06 to 18.10)

< 0.001

ECG/ECD within 24 hours of admission

168/181 (92.8) (90.4 to 96.9)

205/218 (94.0) (90.0 to 96.8)

0.82 (0.35 to 1.94)

0.69

Continuous monitoring within 48 hours of admission (see protocol)

85/229 (37.1) (30.8 to 43.7)

21/219 (9.6) (6.0 to 14.3)

5.57 (3.21 to 9.73)

< 0.001

Before discharge total assessment (see protocol)

200/215 (93.0) (89.4 to 96.3)

176/200 (88.0) (85.1 to 93.9)

1.82 (0.88 to 3.77)

0.09

Use of discharge plan (and communication)

73/214 (34.1) (25.9 to 38.3)

41/200 (20.5) (13.8 to 24.5)

2.01 (1.26 to 3.21)

< 0.01

Use of SIGN guideline-based discharge plan

188/207 (90.8) (86.0 to 94.4)

0 (0.0) (0.0 to 3.7)

999.4 (137.0 to 20374.0)

< 0.001

Use of discharge summary and information (information pack)

190/214 (88.8) (77.5 to 87.6)

134/200 (67.0) (54.4 to 67.7)

3.90 (2.26 to 6.67)

< 0.001

Before discharge assessment with FIM scale

201/209 (96.2) (93.4 to 98.5)

76/168 (45.2) (39.0 to 54.6)

30.41 (13.49 to 71.24)

< 0.001

Follow-up assessment at 3 months with FIM scale

82/86 (95.3) (89.9 to 98.9)

9/29 (31.0) (16.1 to 50.0)

45.56 (11.20 to 205.58)

< 0.001

  1. ABC, Airway, Breathing, Circulation; CT, computed tomography; ECD, Eco-color doppler; FIM, Functional independence measure; MRI, magnietic resonance imaging; SIGN, Scottish Intercollegiate Guideline Network.
  2. aBecause of missing data denominators used to calculate percentages may differ from group totals (clinical pathway versus no intervention).
  3. bValues are n/total n (%) (95% CI) unless otherwise indicated.
  4. c P-values represent comparison of each characteristic between two groups (clinical pathway versus no intervention), and all P-values are two-sided.